( )
Aldevron and Inserm co-develop a novel antibody-based approach for prevention and treatment of chronic hepatitis C
09/10/10 13:53 Filed in: PR
Aldevron’s German division and Inserm (Strasbourg, France), have developed an antibody that blocks the Hepatitis C virus from entering and infecting liver cells. Read More...